BridgeBio
Director/Sr. Director, Business Development & Operations
This range is provided by BridgeBio. Your actual pay will be based on your skills and experience — talk with your recruiter to learn more.
Base pay range
$220,000.00/yr - $295,000.00/yr
What You'll Do
- As the Director/Sr. Director, Business Development & Operations, you will play a key role in shaping the future direction of our Encaleret program. You will lead strategic planning efforts and provide critical insights that influence high-impact decisions. Your expertise will help guide commercial launch readiness, modeling & forecasting, preparation of corporate materials intended for presentation, corporate development, and strategic activities. You will also partner closely with cross-functional teams, including supply chain and operations, to ensure strategic alignment. Your analytical skills and industry experience will directly contribute to the company’s long-term success.
Responsibilities
- Strategic Planning and Execution: Shape and communicate the company’s strategic direction through well-structured presentations that guide prioritization and resource allocation; Lead strategic analyses for program evaluation, including discounted cash flow modeling, and secondary research (e.g., analogs research, epidemiology, claims data analysis); Prepare a strategy to guide the successful US commercialization of encaleret
- Stakeholder Communication: Develop and deliver executive-level PowerPoint presentations that effectively communicate strategic insights, corporate initiatives, and market analyses; Create high-quality visual materials for leadership offsites, Board of Directors meetings, investor discussions & communications, and internal alignment efforts; Ensure presentations are tailored to the audience, synthesizing technical and business content into clear, concise, and actionable messaging; Present and discuss findings of strategic analyses to a variety of audiences, including the Calcilytix team, leadership, and investors; Support corporate development and partnering strategy to ensure that Encaleret can be accessed by patients worldwide
- Supply Chain & Manufacturing Partnership: Partner with Technical Operations and CMC teams to assess long-term supply chain capabilities and infrastructure needs; Develop strategic analyses related to contract manufacturers (CMOs), raw material sourcing, and distribution logistics; Contribute to make-vs-buy decisions, cost optimization, and supply chain resilience planning, especially as pipeline products move toward commercialization
- Cross-functional Partnership: Collaborate with R&D, Regulatory, Finance, Commercial, and Operations to ensure holistic strategy development; Collaborate with functional experts as a strategic partner to support the clinical and commercial success of Encaleret; Collaborate with the BridgeBio commercial team and oversee research in pricing and reimbursement; Lead or contribute to special initiatives involving product lifecycle planning, global expansion, or operational efficiency
Where You'll Work
This is a hybrid role and requires in-office collaboration at least 2-3x per week in our San Francisco or Palo Alto Office.
Who You Are
- A higher degree or equivalent, such as an M.B.A., M.D., or Ph.D., is preferred
- 2-5 years of professional experience in management consulting (life sciences preferred), post-Series A investing, investment banking, venture capital, equity research, and/or corporate role in a therapeutics company
- Prior experience contributing to new product commercialization is a plus
- Proven scientific acumen, communication skills, and an analytical mindset
- A passion for helping patients
- Proficiency in financial modeling, particularly DCF models
- Tenure-appropriate understanding of the drug development life science and operating model. Understands how value is created across the lifespan of a molecules from discovery to commercial execution
- Tenure-appropriate understanding of the biotech landscape
- Exceptional written communication and presentation skills